Register | Forgot password?
Switch to Arabic
Wednesday, November 25 - 2009

Medical technology can create enhanced job market in Middle East, says sector expert

  • United Arab Emirates: Tuesday, March 10 - 2009 at 12:41
  • PRESS RELEASE

Quality and innovation are the mainstays that will enable the Middle East's healthcare sector to pull through the current economic cycle, according to Peggy Farley, co-founder of Ascent Medical Technology Funds.

Article continues below
  • Peggy Farley, co-founder of Ascent Medical Technology Funds.
    Peggy Farley, co-founder of Ascent Medical Technology Funds.
Farley said:
"There is no doubt that we are all faced with the realities of a severely troubled global economy, however, the good news is that the region's healthcare sector is looking set to grow."


She said that the medical technology industry invests heavily in research and development (R&D) and companies, including many start-ups, spend an average of 343 percent of their revenue on R&D.

Farley stated, "Innovation is an essential by-product of the medical manufacturing industry. This coupled with a very high quality of delivery have been the growth pillars of the region's buoyant sector."

"I see the growth in healthcare and medical services sectors as continuing, bringing in its wake new job opportunities, good ROI and then even more innovation as R&D funds are nurtured," she said.

Farley said that this upward cycle will help towards improving overall health of the population, and the GDP.

She added, "Good health is fast becoming one of the Middle East's greatest assets. The pulse of public health has been correctly recognised as a major contributing factor to good economic health - and thus one of increasing importance.

She said that the region has all the right ingredients to become a global healthcare provider, with Governments and private sectors in Dubai, Oman and Jordan particularly, showing commitment in backing the sustained growth of the healthcare industry.

Farley cited recent reports that estimate a 16% annual growth for the healthcare sector in Middle East.

"Healthcare in Dubai alone is expected to grow at 14% to reach $11.9bn by 2015," Farley observed.

Major regional projects such as Dubai Healthcare City (DHCC), the International Medical Centre (IMC) in Jeddah and the Philadelphia Biological and Medical Product Development Centre in Jordan reflect Farley's sentiments.

The strong growth prospects are primarily driven by three developments: the strong healthcare industry and patient flow with the UAE expecting 11.2 million healthcare tourists by the year 2010; an abundance of medical and life sciences professionals; a sophisticated pharmaceutical industry which serves as the base for the expanding MedTech sector.

"The economic climate in world today indicates that it is time for the Middle East to capture and utilise its vast store of intellectual capital and well-channeled financial resources to boost the medical industry," Farley concluded.
Also consider reading:
Log in to request more information from Ascent Group

Notes and media contacts

About Ascent Group:

The Ascent Group comprises companies that provide public capital market and private equity market products and services to institutions and high net individuals. Ascent Medical Technology Fund, LP is the first of the two funds dedicated to funding innovative medical device and life science companies.

Peggy A. Farley is a Managing Director of the General Partner and co-founder of the Ascent Medical Technology Funds. She is the President and Chief Executive Officer of Ascent Capital Management, Inc. Karl Groth Ph.D. is a co-founder with Farley of the Ascent Medical Technology Funds and is President and CEO of the General Partner.

Dr. Karl Groth and Peggy Farley have a long history of working together to fund innovation.

The Ascent Medical Technology Fund II, L.P. (the Fund) was established in year 2007. The Fund is dedicated to advancing medical innovation through investing in early-commercialization stage companies based in the U.S. and the Middle East that have technologies sufficiently innovative to effect dramatic changes in the treatment of serious global health issues such as cardiovascular disease and cancer.

The Fund has as a condition for investment the establishment or development by the company in which it invests, whether domiciled in the US or in the Middle East, a sustainable business in the Middle East (manufacturing facility, lab, clinical research organization, etc.) that will itself seed the emergence of a locus of medical technology activity in the Region to enable the Region to eventually compete with the U.S.

Philadelphia BioMed Product Development Centre is the first of its kind medical centre in Jordan & is managed by the newly established company Philadelphia Biological and Medical Product Development Centre Company, PSC. It is a private shareholding company owned by the Ascent Medical Product Development Centre Inc.

The centre is one of the main four medical innovations launched by Ascent through the initial investments of the Ascent Medical Technology Fund II.

Other projects include Bioheart, Inc., a leader in the realm of cell therapy for heart disease and Heartland Biosciences International, a life science company. Ascent Medical Corporation Inc. is the US affiliate of Salalah Medical Device Manufacturing Company,SAOG, a guide wire manufacturer domiciled in Oman as a joint venture with Salalah Medical Supply Manufacturing Company.

For media enquiries:

Susan Furness
Strategic Solutions for Ascent
Tel.: +9714 3903033

Anu Bhatnagar
Strategic Solutions for Ascent
Tel.: + 9714 3903018

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions